SCHEMBL16320332

SCHEMBL16320332

O=C(NC1CCCCC1)c1cc[c]c(NC2CCCCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.52
NPC1 O15118 9/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
HPGD P15428 3/20 0.50
TP53 P04637 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 1/20 0.49
GFER P55789 1/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
HTR2B P41595 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16320026 0.88 HCAR3 (0.48) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL16320397 0.84 FAAH (0.44)
SCHEMBL16319440 0.83 SMN1; SMN2 (0.48) RAB9ANPC1SMN1; SMN2HPGDKDM4E
SCHEMBL16319748 0.81 FYN (0.43) RAB9ANPC1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16319555 0.80 HPGD (0.45) RAB9ANPC1HPGDCYP1A2CYP2C19
SCHEMBL8170956 0.78 F2 (0.40) KDM4E
SCHEMBL14911306 0.77 NPC1 (0.65) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL16319842 0.76 BMPR1B (0.45) RAB9ANPC1HPGDL3MBTL1LMNA
SCHEMBL6707186 0.75 RAB9A (0.79) RAB9ANPC1SMN1; SMN2HPGDTP53
SCHEMBL730329 0.75 NPC1 (0.62) RAB9ANPC1SMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544684-B1 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-1 (DPP-1) JANSSEN PHARMACEUTICA NV (BE) 2014-12-24 EP disclosed